68 related articles for article (PubMed ID: 1320297)
41. In Silico Mathematical Modelling for Glioblastoma: A Critical Review and a Patient-Specific Case.
Falco J; Agosti A; Vetrano IG; Bizzi A; Restelli F; Broggi M; Schiariti M; DiMeco F; Ferroli P; Ciarletta P; Acerbi F
J Clin Med; 2021 May; 10(10):. PubMed ID: 34067871
[TBL] [Abstract][Full Text] [Related]
42. Clinical implications of in silico mathematical modeling for glioblastoma: a critical review.
Protopapa M; Zygogianni A; Stamatakos GS; Antypas C; Armpilia C; Uzunoglu NK; Kouloulias V
J Neurooncol; 2018 Jan; 136(1):1-11. PubMed ID: 29081039
[TBL] [Abstract][Full Text] [Related]
43. Optimal weekly scheduling in fractionated radiotherapy: effect of an upper bound on the dose fraction size.
Bruni C; Conte F; Papa F; Sinisgalli C
J Math Biol; 2015 Aug; 71(2):361-98. PubMed ID: 25168624
[TBL] [Abstract][Full Text] [Related]
44. Dealing with diversity in computational cancer modeling.
Johnson D; McKeever S; Stamatakos G; Dionysiou D; Graf N; Sakkalis V; Marias K; Wang Z; Deisboeck TS
Cancer Inform; 2013; 12():115-24. PubMed ID: 23700360
[TBL] [Abstract][Full Text] [Related]
45. In silico modelling of treatment-induced tumour cell kill: developments and advances.
Marcu LG; Harriss-Phillips WM
Comput Math Methods Med; 2012; 2012():960256. PubMed ID: 22852024
[TBL] [Abstract][Full Text] [Related]
46. The HYP-RT hypoxic tumour radiotherapy algorithm and accelerated repopulation dose per fraction study.
Harriss-Phillips WM; Bezak E; Yeoh E
Comput Math Methods Med; 2012; 2012():363564. PubMed ID: 22778783
[TBL] [Abstract][Full Text] [Related]
47. Optimal solution for a cancer radiotherapy problem.
Bertuzzi A; Bruni C; Papa F; Sinisgalli C
J Math Biol; 2013 Jan; 66(1-2):311-49. PubMed ID: 22314975
[TBL] [Abstract][Full Text] [Related]
48. Exploiting clinical trial data drastically narrows the window of possible solutions to the problem of clinical adaptation of a multiscale cancer model.
Stamatakos GS; Georgiadi EC; Graf N; Kolokotroni EA; Dionysiou DD
PLoS One; 2011 Mar; 6(3):e17594. PubMed ID: 21407827
[TBL] [Abstract][Full Text] [Related]
49. Introduction of hypermatrix and operator notation into a discrete mathematics simulation model of malignant tumour response to therapeutic schemes in vivo. Some operator properties.
Stamatakos GS; Dionysiou DD
Cancer Inform; 2009 Oct; 7():239-51. PubMed ID: 20011462
[TBL] [Abstract][Full Text] [Related]
50. Critical parameters determining standard radiotherapy treatment outcome for glioblastoma multiforme: a computer simulation.
Dionysiou DD; Stamatakos GS; Gintides D; Uzunoglu N; Kyriaki K
Open Biomed Eng J; 2008 Sep; 2():43-51. PubMed ID: 19662116
[TBL] [Abstract][Full Text] [Related]
51. [Medicine and technique: computer simulations in cancer research].
Düchting W
Med Klin (Munich); 1998 Sep; 93(9):565-70. PubMed ID: 9792026
[No Abstract] [Full Text] [Related]
52. Radiogenic responses of normal cells induced by fractionated irradiation--a simulation study. Part II. Late responses.
Düchting W; Ulmer W; Ginsberg T; Kikhounga-N'Got O; Saile C
Strahlenther Onkol; 1995 Sep; 171(9):525-33. PubMed ID: 7570301
[TBL] [Abstract][Full Text] [Related]
53. Computer simulation of clinical irradiation schemes applied to in vitro tumor spheroids.
Düchting W; Lehrig R; Rademacher G; Ulmer W
Strahlenther Onkol; 1989 Dec; 165(12):873-8. PubMed ID: 2603123
[TBL] [Abstract][Full Text] [Related]
54. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
55. Computer simulation and modelling of tumor spheroid growth and their relevance for optimization of fractionated radiotherapy.
Düchting W; Ulmer W; Lehrig R; Ginsberg T; Dedeleit E
Strahlenther Onkol; 1992 Jun; 168(6):354-60. PubMed ID: 1320297
[TBL] [Abstract][Full Text] [Related]
56. Computer simulation of fractionated radiotherapy: further results and their relevance to percutaneous irradiation and brachytherapy.
Ginsberg T; Ulmer W; Düchting W
Strahlenther Onkol; 1993 May; 169(5):304-10. PubMed ID: 8503090
[TBL] [Abstract][Full Text] [Related]
57. Modeling of radiogenic responses induced by fractionated irradiation in malignant and normal tissue.
Düchting W; Ginsberg T; Ulmer W
Stem Cells; 1995 May; 13 Suppl 1():301-6. PubMed ID: 7488961
[TBL] [Abstract][Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]